Bellevue Asset Management (Switzerland)’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q4	$604K	Sell	14,000 -19,000	-58%	-$820K	0.09%	112
2015 Q3	$1.24M	Sell	33,000 -5,000	-13%	-$187K	0.2%	100
2015 Q2	$1.29M	Buy	38,000 +14,000	+58%	+$476K	0.18%	104
2015 Q1	$850K	Buy	+24,000	New	+$850K	0.12%	121